Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-007204
Filing Date
2024-02-20
Accepted
2024-02-20 15:35:09
Documents
75
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1562263
2 ex31-1.htm EX-31.1 11617
3 ex31-2.htm EX-31.2 11655
4 ex32-1.htm EX-32.1 6541
  Complete submission text file 0001493152-24-007204.txt   9732644

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ther-20231231.xsd EX-101.SCH 66648
6 XBRL CALCULATION FILE ther-20231231_cal.xml EX-101.CAL 68814
7 XBRL DEFINITION FILE ther-20231231_def.xml EX-101.DEF 342774
8 XBRL LABEL FILE ther-20231231_lab.xml EX-101.LAB 548613
9 XBRL PRESENTATION FILE ther-20231231_pre.xml EX-101.PRE 436773
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1482876
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

EIN.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 24652968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)